319 related articles for article (PubMed ID: 11550120)
21. The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
Kim JS; Cheong JW; Kim YK; Park J; Mun YC; Kang HJ; Yi HG; Lee JH; Kim YS; Ryoo HM; Kim SH; Kim HY; Kim JY; Lee DG; Kim HG; Kim H; Joo YD; Min YH
Ann Hematol; 2014 Jan; 93(1):33-42. PubMed ID: 23807252
[TBL] [Abstract][Full Text] [Related]
22. [Chronic necrotizing pulmonary aspergillosis treated with itraconazole and inhaled amphotericin B].
Sato A; Nakatani K; Matsushita Y; Matsuo H; Yamadori H; Kurasawa T; Ikeda Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1141-5. PubMed ID: 8544389
[TBL] [Abstract][Full Text] [Related]
23. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
Cornely OA; Maertens J; Bresnik M; Ebrahimi R; Ullmann AJ; Bouza E; Heussel CP; Lortholary O; Rieger C; Boehme A; Aoun M; Horst HA; Thiebaut A; Ruhnke M; Reichert D; Vianelli N; Krause SW; Olavarria E; Herbrecht R;
Clin Infect Dis; 2007 May; 44(10):1289-97. PubMed ID: 17443465
[TBL] [Abstract][Full Text] [Related]
24. Itraconazole disposition after single oral and intravenous and multiple oral dosing in healthy cats.
Boothe DM; Herring I; Calvin J; Way N; Dvorak J
Am J Vet Res; 1997 Aug; 58(8):872-7. PubMed ID: 9256973
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases.
Nam HS; Jeon K; Um SW; Suh GY; Chung MP; Kim H; Kwon OJ; Koh WJ
Int J Infect Dis; 2010 Jun; 14(6):e479-82. PubMed ID: 19910234
[TBL] [Abstract][Full Text] [Related]
26. [Sequential intravenous and oral itraconazole in treatment of invasive fungal infection in hematological diseases].
; Chen Y; Shen ZX
Zhonghua Nei Ke Za Zhi; 2008 Dec; 47(12):1026-9. PubMed ID: 19134310
[TBL] [Abstract][Full Text] [Related]
27. [Therapy of invasive aspergillosis with itraconazole: our own experiences and review of the literature].
Kreisel W
Mycoses; 1994; 37 Suppl 2():42-51. PubMed ID: 7609743
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice.
Tansho S; Abe S; Ishibashi H; Torii S; Otani H; Ono Y; Yamaguchi H
J Infect Chemother; 2006 Dec; 12(6):355-62. PubMed ID: 17235640
[TBL] [Abstract][Full Text] [Related]
29. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.
Alvarez CA; Wiederhold NP; McConville JT; Peters JI; Najvar LK; Graybill JR; Coalson JJ; Talbert RL; Burgess DS; Bocanegra R; Johnston KP; Williams RO
J Infect; 2007 Jul; 55(1):68-74. PubMed ID: 17360039
[TBL] [Abstract][Full Text] [Related]
30. Itraconazole to prevent fungal infections in chronic granulomatous disease.
Gallin JI; Alling DW; Malech HL; Wesley R; Koziol D; Marciano B; Eisenstein EM; Turner ML; DeCarlo ES; Starling JM; Holland SM
N Engl J Med; 2003 Jun; 348(24):2416-22. PubMed ID: 12802027
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of invasive cavernous sinus aspergillosis with oral itraconazole monotherapy.
Browning AC; Sim KT; Timms JM; Vernon SA; McConachie NS; Allibone R; Jones NS
J Neuroophthalmol; 2006 Jun; 26(2):103-6. PubMed ID: 16845309
[TBL] [Abstract][Full Text] [Related]
32. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
Tomioka H; Kaneda T; Kida Y; Kaneko M; Fujii H; Hayashi M; Tomii K; Tada K; Suzuki Y; Karino T
Kansenshogaku Zasshi; 2011 Nov; 85(6):644-51. PubMed ID: 22250455
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation.
Michallet M; Persat F; Kranzhöfer N; Levron JC; Prat C; Belhabri A; Chwetzoff E; Le Moing JP; Fiere D; Piens MA
Bone Marrow Transplant; 1998 Jun; 21(12):1239-43. PubMed ID: 9674858
[TBL] [Abstract][Full Text] [Related]
34. [Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies].
Zhu Y; Chen SP; Shu YG; Xu YJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):89-92. PubMed ID: 18245913
[TBL] [Abstract][Full Text] [Related]
35. Caspofungin: new preparation. A last resort in invasive aspergillosis.
Prescrire Int; 2002 Oct; 11(61):142-3. PubMed ID: 12378745
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of primary cutaneous Aspergillus flavus infection of the hand with oral itraconazole.
Epstein MD; Segalman KA; Mulholland JH; Orbegoso CM
J Hand Surg Am; 1996 Nov; 21(6):1106-8. PubMed ID: 8969443
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy of intravenous administration of itraconazole on fungal infections in immunocompromised patients with hematological diseases].
Wang JZ; Huang XJ; Liu KY; Liu DH; Chen H; Xu LP; Lu J; Zhang YC; Han W; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1481-3. PubMed ID: 16061027
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
Denning DW; Ribaud P; Milpied N; Caillot D; Herbrecht R; Thiel E; Haas A; Ruhnke M; Lode H
Clin Infect Dis; 2002 Mar; 34(5):563-71. PubMed ID: 11807679
[TBL] [Abstract][Full Text] [Related]
39. [Conversion of chronic necrotizing pulmonary aspergillosis to invasive pulmonary aspergillosis, and successful treatment with fluconazole].
Hirano K; Saitoh T; Kadono K; Oose H; Watanabe S; Hasegawa S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Apr; 35(4):408-13. PubMed ID: 9212665
[TBL] [Abstract][Full Text] [Related]
40. Population pharmacokinetics of intravenous itraconazole in patients with persistent neutropenic fever.
Lee DG; Chae H; Yim DS; Park SH; Choi SM; Kim S; Choi JH; Yoo JH; Shin WS
J Clin Pharm Ther; 2009 Jun; 34(3):337-44. PubMed ID: 19646080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
